62.19
1.23%
+0.755
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
ANI Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.13%
131.65
|
131.83 | 116.55 | 106.79 | 94.23 |
Operating Expenses
|
9.70%
124.93
|
113.88 | 104.14 | 96.89 | 92.41 |
Benefits Costs and Expenses |
8.63%
130.71
|
120.32 | 111.30 | 104.62 | 99.96 |
Costs And Expenses |
9.70%
124.93
|
113.88 | 104.14 | 96.89 | 92.41 |
Depreciation and Amortization |
0.09%
15.19
|
15.21 | 14.69 | 14.70 | 14.48 |
Operating Income/Loss |
62.53%
6.726
|
17.95 | 12.40 | 9.895 | 1.82 |
Income/Loss From Continuing Operations Before Tax |
91.77%
0.947
|
11.51 | 5.249 | 2.165 | -5.728 |
Income Tax Expense/Benefit |
113.24%
-0.208
|
1.571 | -0.996 | 0.726 | -1.485 |
Income/Loss From Continuing Operations After Tax |
88.38%
1.155
|
9.94 | 6.245 | 1.439 | -4.243 |
Net Income/Loss
|
88.38%
1.155
|
9.94 | 6.245 | 1.439 | -4.243 |
Preferred Stock Dividends And Other Adjustments |
0.00%
0.406
|
0.406 | 0.407 | 0.406 | 0.407 |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
98.21%
0.338
|
18.88 | 17.69 | 16.39 | 0.022 |
Diluted Average Shares |
98.06%
0.371
|
19.12 | 17.86 | 16.53 | 0.022 |
Basic Earnings Per Share |
95.65%
0.02
|
0.46 | 0.30 | 0.06 | -0.29 |
Diluted Earnings Per Share |
95.56%
0.02
|
0.45 | 0.29 | 0.06 | -0.29 |
Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
94.39%
0.05
|
0.891 | 0.589 | 0.113 | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
64.84%
0.456
|
1.297 | 0.996 | 0.519 | 0.407 |
Capitalizzazione:
|
Volume (24 ore):